Anne Heyes, MBA

Vice President, Head Market Access and Outcomes Strategy, Europe

MBA
Diploma, Health Economics Research
University of Keele, Keele, United Kingdom

BSc, Botany
University of Sheffield, Sheffield, United Kingdom

Anne Heyes, MBA, is Head of Market Access and Outcomes Strategy, Europe, and is based in RTI-HS’s office in Manchester, UK. Ms. Heyes has more than 30 years of industry and consultancy experience, including leadership roles in Global Health Economics and Outcomes Research at AstraZeneca, where she was responsible for the development and implementation of market access strategies and evidence generation to support new products. She then led the UK-based market access team within an international consultancy. She has experience in drug development and market access in the clinical and commercial arenas in both global and local settings. Ms. Heyes has experience in all aspects of market access evidence development and implementation, including development of global value dossiers, payer research, health economic analyses, value communication, trial design, and health technology assessment submissions. She leads a team of specialists responsible for providing clients with effective, tailored solutions to support market access for new products. Ms. Heyes has experience in a wide range of therapeutic areas, including oncology, pain, diabetes, immunosuppression, gastroenterology, cardiovascular, urology, central nervous system, and hematological disorders. She is a member of the International Society for Pharmacoeconomics and Outcomes Research.